Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Researchers and Healthcare Providers
 Research Grants Program
-Medical and Scientific Advisory Council
 Recent Recommendations
 What is MASAC?
 All MASAC Recommendations
 MASAC Members
 Nursing Working Group
 Social Work Working Group
 Physical Therapy Working Group
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Cell Based Coagulation Animation
 Rare Bleeding and Clotting Disorders Resource Room
 The Partners in Bleeding Disorders Education Program
 NHF/Novo Nordisk HANDI Library

 

 

 
MASAC Document #161- MASAC RESOLUTION ON STEM CELL RESEARCH FOR POTENTIAL CURE O
 

MASAC Document #161

MASAC RESOLUTION ON STEM CELL RESEARCH FOR POTENTIAL CURE OF BLEEDING DISORDERS

View Printer-Friendly PDF Version >>

The following recommendations were approved by the Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation on April 8, 2005, and adopted by the NHF Board of Directors on June 4, 2005

Embryonic and adult stem cell research offers the potential to cure hemophi1ia and other bleeding disorders and their complications.

The Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation unanimously supports embryonic and adult stem cell research as a legitimate and important area of scientific investigation and as a vital avenue of research toward curing hemophilia and other bleeding disorders. MASAC supports the application of appropriate standards to safeguard individual rights and minimize potential for abuse of this important resource.





.


This material is provided for your general information only. NHF does not give medical advice or engage in the practice of medicine. NHF under no circumstances recommends particular treatment for specific individuals and in all cases recommends that you consult your physician or local treatment center before pursuing any course of treatment.

Copyright 2003 National Hemophilia Foundation. To facilitate the dissemination of these medical recommendations, reproduction of any material in this publication in whole or in part will be permitted provided: 1) a specific reference to the MASAC recommendation number and title is included and 2) the reproduction is not intended for use in connection with the marketing, sale or promotion of any product or service. NHF reserves the right to make the final determination of compliance with this policy. For questions or to obtain a copy of the most recent recommendations, please contact the NHF Director of Communications at 1-800-42-HANDI or visit the NHF website at www.hemophilia.org.